Advertisement
Advertisement
Eli Lilly and Company (LLY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:05PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 312.72 |
| Open | 319.55 |
| Bid | 324.10 x 1300 |
| Ask | 325.00 x 1000 |
| Day's Range | 319.01 - 325.82 |
| 52 Week Range | 220.20 - 325.82 |
| Volume | |
| Avg. Volume | 3,084,046 |
| Market Cap | 311.485B |
| Beta (5Y Monthly) | 0.43 |
| PE Ratio (TTM) | 49.71 |
| EPS (TTM) | 6.55 |
| Earnings Date | Apr 25, 2022 - Apr 29, 2022 |
| Forward Dividend & Yield | 3.92 (1.34%) |
| Ex-Dividend Date | May 13, 2022 |
| 1y Target Est | 304.28 |
- Zacks
Radius (RDUS) to Go Private With $890M Deal, Shares Gain
Radius (RDUS) will go private following the acquisition by Gurnet Point Capital and Patient Square Capital.
- Barrons.com
Zoom Stock and 2 Others With Recession-Resistant Earnings
Wall Street is likely poised to scale back its forecasts for profits, with ugly consequences for stocks, so investors will want to identify companies that are immune.
- Zacks
Radius (RDUS), Menarini Submit NDA for Breast Cancer Drug
Radius (RDUS) and partner The Menarini Group submit a new drug application to the FDA for elacestrant for treating patients with ER+/HER2- advanced or metastatic breast cancer.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
